iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)

CAPS Rating: 3 out of 5

Exchange Traded Funds

Recs

2
Player Avatar ravens9111 (65.58) Submitted: 3/26/2012 6:13:47 PM : Outperform Start Price: $123.77 IBB Score: +53.00

Playing individual biotech stocks is risky business. This is probably the least risky way to play the sector without taking a chance of waking up one morning to see the company's drug was rejected and opens down 50%+ on an FDA rejection.

Featured Broker Partners


Advertisement